(Press-News.org) ANN ARBOR--New research at the University of Michigan offers evidence that a drug being developed to treat osteoporosis may also be useful for treating osteogenesis imperfecta or brittle bone disease, a rare but potentially debilitating bone disorder that that is present from birth.
Previous studies have shown the drug to be effective at spurring new bone growth in mice and in humans with osteoporosis, and a U-M research team believes that it may spur new growth in brittle bone disease patients as well. This would be a significant improvement over current treatments, which can only reduce the loss of existing bone.
The new drug is an antibody to a protein called sclerostin, which normally signals the body to stop producing new bone. Previous studies have shown that inhibiting sclerostin through antibody therapy is effective at increasing bone formation and strength.
The new U-M study focused on the effects of the antibody in very young and very old mice with genetic features that mimic brittle bone disease. Researchers were particularly interested in studying the effects of the drug on young mice, which are still growing new bone and have much lower levels of sclerostin.
"The dynamics of bone growth in young mice and in children are very different from those in adults," said Ken Kozloff, associate professor of orthopaedic surgery and biomedical engineering. "Their bone structures are still forming, so it's important to understand how inhibiting sclerostin may affect that. We were also concerned that the benefits of the drug would reverse themselves after treatment stopped."
The results of the study are encouraging, with no reduction in midshaft bone strength or mass in young mice six weeks after treatment stopped. While there was some loss in newly formed spongy bone, the researchers found that this could be remedied by using the sclerostin antibody in combination with other therapies.
Osteogenesis imperfecta is a genetic disease that affects an estimated 20,000 to 50,000 people in the United States, about 1 in 20,000 live births. It reduces the body's ability to form new bone and weakens the bone that does form. This leads to bones that fracture easily in everyday activities, causing a cycle of repeated fractures and hospitalizations.
There is no cure and current treatment options are limited. They include the use of bisphosphonate drugs to reduce the weakening of bone and the surgical implantation of steel rods in the bones to improve their strength.
"I envision a treatment that uses a precise combination of sclerostin antibodies to grow new bone, followed by bisphosphonates to lock in that bone growth," said Michelle Caird, associate professor of orthopaedic surgery who specializes in brittle bone disease. "The rodent studies we're doing right now are giving us a better understanding of how to optimize the timing and amounts of the two drugs. We have years of hard work ahead of us, but I think this could really improve quality of life for kids with this disease."
The research team still has an estimated two years of rodent studies to complete. They're hopeful that patients may have a new treatment option within the next five to six years. Amgen, the manufacturer of the drug and the provider of the drugs used in the U-M study, is currently testing on osteoporosis patients.
Caird says the data gained from that testing may help a new treatment for brittle bone disease get through the testing and approval process more quickly. The team is also working on new study methods that may enable them to test the new drug in the lab on small samples of bone cells taken from patients.
Researchers believe that the therapy may also be useful for treating children who suffer from disuse osteopenia, a bone disorder that can result when bones don't bear normal amounts of weight. This is common among children who use wheelchairs as a result of diseases like cerebral palsy and spina bifida.
"Disuse osteopenia is the same disease that astronauts get when they're in microgravity environments for long periods of time," Caird said. "It affects many more children than brittle bone disease, so we're very hopeful that sclerostin antibody therapy will be a useful treatment for them as well. But we're focusing on brittle bone disease first because it's particularly debilitating and because there are so few other options for those kids."
INFORMATION:
An abstract titled "Single Dose of Bisphosphonate Preserves Long-term Gains in Bone Mass Following Cessation of Sclerostin Antibody in Osteogenesis Imperfecta Model" will be presented March 31 at the annual meeting of the Orthopaedic Research Society. The research was funded by the National Institutes of Health. Drugs for the study were provided by Amgen and UCB.
Until now electric fences and trenches have proved to be the most effective way of protecting farms and villages from night time raids by hungry elephants. But researchers think they may have come up with another solution - the recorded sound of angry predators.
The research carried out in southern India by Dr Vivek Thuppil at The University of Nottingham Malaysia Campus and Dr Richard G Coss from the University of California, Davis has been published in Oryx - The International Journal of Conservation.
Using an infrared sensor playback system elephants triggered the ...
This news release is available in German.
Leipzig, Columbia (SC), Munich. The ocean is a large reservoir of dissolved organic molecules, and many of these molecules are stable against microbial utilization for hundreds to thousands of years. They contain a similar amount of carbon as compared to carbon dioxide (CO2) in the atmosphere. Researchers at the Helmholtz Centre for Environmental Research (UFZ), the University of South Carolina and the Helmholtz Centre Munich found answers to questions about the origin of these persistent molecules in a study published in ...
"Planck detects, then Herschel analyzes". That's how Gianfranco De Zotti, professor at the International School for Advanced Studies (SISSA) in Trieste and at INAF-Astronomical Observatory of Padova, summarizes the rationale of the study just published in Astronomy & Astrophysics. "As Mattia Negrello had already suggested in 2005, it is precisely Planck's low resolution - optimized for the study of the cosmic microwave background but a major limitation for identifying extragalactic sources - which makes the satellite a powerful tool in the search for large-scale structures. ...
In a survey of over 600 young Finns, 76% of respondents listened to music from YouTube every day.
YouTube and Spotify were by far the most popular music sources in the study. YouTube was the most frequently used service for music listening and new music discovery. Even active Spotify users visited YouTube often to complement Spotify's incomplete music selection. YouTube was also perceived as the most shareable music source by the Finnish students in their early 20s who participated in the internet-based study.
The popularity of YouTube was overwhelming. Nearly everyone ...
Using the assessment tool ForWarn, U.S. Forest Service researchers can monitor the growth and development of vegetation that signals winter's end and the awakening of a new growing season. Now these researchers have devised a way to more precisely characterize the beginning of seasonal greening, or "greenup," and compare its timing with that of the 14 previous years. Such information helps land managers anticipate and plan for the impacts of disturbances such as weather events and insect pests.
Three maps detailing greenup in forests and grasslands, agricultural lands, ...
Children who play video games for more than three hours a day are more likely to be hyperactive, get involved in fights and not be interested in school, says a new study. It examined the effects of different types of games and time spent playing on children's social and academic behaviour. The researchers from the University of Oxford found that the time spent playing games could be linked with problem behaviour and this was the significant factor rather than the types of games played. They could find no link between playing violent games and real-life aggression or a child's ...
Sitting with a joystick in the comfort of their chairs, scientists can play "rodeo" on a screen magnifying what is happening under their microscope. They rely on optical tweezers to manipulate an intangible ring created out of liquid crystal defects capable of attaching a microsphere to a long thin fibre. Maryam Nikkhou and colleagues from the Jožef Stefan Institute, in Ljubljana, Slovenia, recently published in EPJ E the results of work performed under the supervision of Igor Muševič. They believe that their findings could ultimately open the door to controlling ...
The Internet brings the world to our fingertips, but it turns out that getting information online also has a startling effect on our brains: We feel a lot smarter than we really are, according to a Yale-led study published March 30 in the Journal of Experimental Psychology.
In nine different experiments with more than 1,000 participants, Yale psychologists found that if subjects received information through Internet searches, they rated their knowledge base as much greater than those who obtained the information through other methods.
"This was a very robust effect, ...
WASHINGTON - Searching the Internet for information may make people feel smarter than they actually are, according to new research published by the American Psychological Association.
"The Internet is such a powerful environment, where you can enter any question, and you basically have access to the world's knowledge at your fingertips," said lead researcher Matthew Fisher, a fourth-year doctoral candidate in psychology at Yale University. "It becomes easier to confuse your own knowledge with this external source. When people are truly on their own, they may be wildly ...
PHILADELPHIA - HIV (human immunodeficiency virus)-positive kidney transplant patients experienced superior outcomes when compared to kidney transplant patients with Hepatitis C and those infected with both HIV and Hepatitis C, according to a study led by researchers at the Perelman School of Medicine at the University of Pennsylvania and published online in Kidney International.
The research team examined outcomes of 124,035 adult kidney recipients transplanted between 1996 and 2013, and found the three-year survival rate of HIV patients (89 percent) was actually very ...
